130.69USD-2.02%Mkt Cap: 36.91B $P/E: 26.245d ago
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Mark…
Industry Peers
Diagnostics & Researchvs Diagnostics & Research
P/E
Avg
P/B
Pricier
Div Yield
Higher
1M Perf
Higher
$192.35BUSDP/E 28.4
$137.04BUSDP/E 37.5
$46.27BUSDP/E 44.7
$44.57BUSDP/E 41.5
$40.64BUSD
$37.20BUSDP/E 48.3
$34.38BUSDP/E 25.6
$29.40BUSDP/E 35.4
$26.44BUSDP/E 30.8
$23.63BUSDP/E 23.6
$23.32BUSDP/E 25.2
$22.39BUSD
$16.14BUSDP/E 35.6
$12.93BUSDP/E 26.9
$12.60BUSDP/E 54.3
$11.15BUSD
$8.92BUSDP/E 20.8
$6.22BUSD
$5.68BUSDP/E 228.5
$5.42BUSD
$5.09BUSDP/E 43.6
$4.63BUSDP/E 53.7
$3.77BUSDP/E 26.7
$3.39BUSD
$2.96BUSD
$2.05BUSD
$1.97BUSD
$1.53BUSDP/E 38.7
$1.55BUSDP/E 23.5
$1.50BUSD
$1.50BUSD
$1.13BUSD
$1.02BUSDP/E 21.3
$734.29MUSD
$645.18MUSDP/E 42.0
$607.49MUSD
$569.52MUSD
$300.57MUSDP/E 3.0
$290.61MUSD
$226.27MUSD
$182.12MUSD
$141.76MUSD
$106.30MUSD
$97.25MUSD
$94.30MUSDP/E 18.1
$80.04MUSD
$58.94MUSD
$45.15MUSD
$33.01MUSD
$30.57MUSD
$22.69MUSD
$18.66MUSD
$12.29MUSD
$12.18MUSD
$9.96MUSDP/E 62.5
$9.42MUSD
$9.20MUSD
$6.29MUSD
$6.08MUSD
$5.13MUSD
$5.08MUSD
$5.06MUSD
$3.86MUSDP/E 2.8
$3.69MUSD
$3.29MUSD
$2.79MUSD
$2.11MUSD
$1.01MUSD
$314.2KUSDP/E Infinity
$56.1KUSD
Indicators:|
Key Statistics
Company
Market Cap36.91B $
Enterprise Value39.25B $
Revenue (TTM)7.23B $
Gross Profit3.64B $
Net Income (TTM)1.30B $
Revenue/Share25.55 USD
Last Price130.69 USD
Fiscal Year EndOct 2025
MR QuarterApr 2026
Employees18.0K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISINUS00846U1016
Valuation
P/E (Trailing)26.24
P/E (Forward)20.09
PEG1.34
EV/EBITDA19.48
EV/Revenue5.43
P/S5.19
P/B5.26
EPS (TTM)4.98
EPS (Forward)6.61
52W Range
108.3543% of range160.27
52W High160.27 USD
52W Low108.35 USD
Profitability
Gross Margin52.43%
Oper. Margin23.71%
EBITDA Margin27.86%
Profit Margin18.75%
ROE19.33%
ROA10.24%
Growth
Revenue Growth10.00%
Earnings Growth60.00%
Cash Flow & Leverage
Operating CF1.56B $
CapEx (TTM)407.00M $
FCF Margin12.87%
FCF Yield2.52%
Net Debt1.74B $
Net Debt/EBITDA0.86
Balance Sheet
Debt/Equity0.50
Current Ratio2.10
Quick Ratio1.46
Book Value/Sh25.24 USD
Cash/Share6.398 USD
Dividends
Fwd Div Rate1.020 USD
Trail. Div Rate1.006 USD
Div. Yield0.77%
5Y Avg Yield0.68%
Payout Ratio20.20%
Ex-Div DateJun 30, 2026
Pay DateJul 22, 2026
Splits
Last Split1398:1000
Split DateNov 3, 2014
Analyst Consensus
Rating1.6 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)160.33 USD
Upside (mean)+22.7%
Target Range144.00 USD – 185.00 USD
$144.00+22.7% to mean$185.00
# Analysts18
Ownership
Shares Out.282.43M
Float281.47M
Insiders0.19%
Institutions94.08%
Short Interest
Short Ratio2.1d
Short % Float2.28%
Short % Out.2.00%
Shares Short5.66M
Short (prev mo.)5.50M
Technical
SMA 50122.80 (+6.4%)
SMA 200130.58 (+0.1%)
Beta1.26
S&P 52W Chg20.05%
Avg Vol (30d)1.68M
Avg Vol (10d)2.46M
Technical Indicators
RSI (14)52.9
MACD2.2635
MACD Signal2.5218
MACD Hist.-0.2583
BB Upper139.56 USD
BB Middle131.70 USD
BB Lower123.84 USD
BB Width11.94%
ATR (14)4.282 USD
Vol Ratio (20d)0.85x